2026/03/02 by Rosie Kidane, Jarco Wesdorp, Stefanie Duijndam +3 · 1 voice
Psychology · Medicine · #Personality Disorders and Psychopathology #Digital Mental Health Interventions #Bipolar Disorder and Treatment
paper · doi:10.1037/per0000760
openalex publication_date 2026/03/02 · openalex created_date 2026/03/03 · openalex updated_date 2026/08/01
= 11.85; range: 14-61 years). After establishing interrater reliability, a retrospective analysis of routine clinical data was used to examine the relationship between two clinical staging models and one risk profile model on total treatment dosage and outcome. The results showed that staging models and risk profiles could be reliably assessed and that patients in earlier stages required less treatment and achieved better outcomes compared with later stages. However, the contribution of risk profiling was minimal and insignificant. Furthermore, results suggest that the transition from Stage 1 to Stage 2 represents a critical turning point in BPD progression and underscores the importance of early intervention. Despite limitations, clinical staging models explained significant variance in treatment dosage and symptom reduction, offering valuable insights into BPD treatment needs. The study highlights the potential of these models to support early detection and intervention by improving prognosis and guiding more personalized treatment. (PsycInfo Database Record (c) 2026 APA, all rights reserved).